微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | -7.64% | -69.8% | -67.55% | 129/158 | 1.25% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | -4.56% | -716.22% | -430.23% | 129/158 | 0.28% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | -0.86% | -161.43% | 97.31% | 124/158 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | -32.01% | -11755.56% | -611.38% | 139/158 | -9.6% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | -4.5% | -9190.3% | -708.07% | 128/158 | 4.24% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 0.74% | -71.54% | -47.14% | 105/158 | 2.68% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 1.4% | 47.37% | 618.52% | 76/158 | 2.33% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -0.27% | 95.91% | -645.45% | 104/158 | -1% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 0.05% | -95.24% | -98.1% | 116/158 | 2.35% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 2.6% | 198.85% | 173.68% | 73/158 | 1.47% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 0.95% | 13.1% | 114.39% | 94/158 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | -6.6% | 43.3% | -734.62% | 120/158 | 0.72% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 1.04% | -68.96% | 19.54% | 103/158 | 2.84% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 0.87% | -55.15% | 3.57% | 105/158 | 2.19% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 0.84% | -45.1% | 107.22% | 98/158 | 1.58% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | -11.64% | -216.28% | -447.46% | 131/158 | 0.79% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | 3.35% | -46.99% | 72.68% | 93/158 | 4.44% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 1.94% | -63.81% | 26.8% | 98/158 | 2.97% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 1.53% | -79.95% | -84.72% | 76/158 | 2.47% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 10.01% | -68.2% | 58.39% | 53/158 | 3.66% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 6.32% | 2% | 17.91% | 63/158 | 3.07% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 5.36% | -60.3% | -29.75% | 49/158 | 4.23% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 7.63% | 2% | -75.76% | 6/158 | 2.2% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 31.48% | 36.22% | 133.19% | 3/158 | 2.57% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-06-30 | 13.5% | 2% | -41.58% | 5/158 | 5% | 奥赛康 | 35% | 行业排名> |
| 2018-12-31 | 23.11% | 76.82% | 76.82% | 8/158 | 7.17% | 奥赛康 | 28.15% | 行业排名> |
| 2017-12-31 | 13.07% | -84% | -84% | 29/158 | 9.68% | 宏源药业 | 21.91% | 行业排名> |
| 2016-12-31 | 81.7% | 2% | 2% | 1/158 | 6.22% | 奥赛康 | 9.7% | 行业排名> |